![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Tzeplaeff, Laura 
ORCID: https://orcid.org/0009-0003-7643-3232; Galhoz, Ana; Meijs, Clara; Caldi Gomes, Lucas; Kovac, Andrej; Menzel, Amrei; Değirmenci, Hatice; Alaamel, Abir; Kaya, Hüseyin Can; Çelik, Ali Günalp; Dinçer, Sine; Korucuk, Meltem; Karaüzüm, Sibel Berker; Bayraktar, Elif; Çiftçi, Vildan; Bilge, Uğur; Koç, Filiz; Demleitner, Antonia F.; Buchberger, Anne; Heynitz, Ricarda von; Gmeiner, Vincent; Knellwolf, Christina; Mouzouri, Mohammed; Wuu, Joanne; Başak, A. Nazli; Andersen, Peter Munch; Kohlmayer, Florian; Ashton, Nicholas J.; Kuban, Wojciech; Lenz, Christof; Rogers, Mary-Louise; Zilka, Norbert; Corcia, Philippe; Lerner, Yossef; Weber, Markus; Turcanova Koprusakova, Monika; Uysal, Hilmi; Benatar, Michael; Menden, Michael P. und Lingor, Paul ORCID: https://orcid.org/0000-0001-9362-7096
(2025):
Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS study.
In: Neurological Research and Practice, Bd. 7, 56
[PDF, 1MB]
ORCID: https://orcid.org/0009-0003-7643-3232; Galhoz, Ana; Meijs, Clara; Caldi Gomes, Lucas; Kovac, Andrej; Menzel, Amrei; Değirmenci, Hatice; Alaamel, Abir; Kaya, Hüseyin Can; Çelik, Ali Günalp; Dinçer, Sine; Korucuk, Meltem; Karaüzüm, Sibel Berker; Bayraktar, Elif; Çiftçi, Vildan; Bilge, Uğur; Koç, Filiz; Demleitner, Antonia F.; Buchberger, Anne; Heynitz, Ricarda von; Gmeiner, Vincent; Knellwolf, Christina; Mouzouri, Mohammed; Wuu, Joanne; Başak, A. Nazli; Andersen, Peter Munch; Kohlmayer, Florian; Ashton, Nicholas J.; Kuban, Wojciech; Lenz, Christof; Rogers, Mary-Louise; Zilka, Norbert; Corcia, Philippe; Lerner, Yossef; Weber, Markus; Turcanova Koprusakova, Monika; Uysal, Hilmi; Benatar, Michael; Menden, Michael P. und Lingor, Paul ORCID: https://orcid.org/0000-0001-9362-7096
(2025):
Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS study.
In: Neurological Research and Practice, Bd. 7, 56
[PDF, 1MB]
Koch, Jan C; Leha, Andreas; Bidner, Helen; Cordts, Isabell; Dorst, Johannes; Günther, René; Zeller, Daniel; Braun, Nathalie; Metelmann, Moritz; Corcia, Philippe; Cruz, Elisa De La; Weydt, Patrick; Meyer, Thomas; Großkreutz, Julian; Soriani, Marie-Hélène; Attarian, Shahram; Weishaupt, Jochen H; Weyen, Ute; Kuttler, Josua; Zurek, Gabriela; Rogers, Mary-Louise; Feneberg, Emily; Deschauer, Marcus ORCID: https://orcid.org/0000-0001-6116-6790; Neuwirth, Christoph; Wuu, Joanne; Ludolph, Albert C; Schmidt, Jens; Remane, Yvonne; Camu, William; Friede, Tim; Benatar, Michael; Weber, Markus und Lingor, Paul
(2024):
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS). A phase 2, randomised, double-blind, placebo-controlled trial.
In: Lancet Neurology, Bd. 23, Nr. 11: S. 1133-1146
[PDF, 849kB]
ORCID: https://orcid.org/0000-0001-6116-6790; Neuwirth, Christoph; Wuu, Joanne; Ludolph, Albert C; Schmidt, Jens; Remane, Yvonne; Camu, William; Friede, Tim; Benatar, Michael; Weber, Markus und Lingor, Paul
(2024):
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS). A phase 2, randomised, double-blind, placebo-controlled trial.
In: Lancet Neurology, Bd. 23, Nr. 11: S. 1133-1146
[PDF, 849kB]